title: High DNA-methyltransferase 3B expression predicts poor outcome in acute myeloid leukemia, especially among patients with co-occurring NPM1 and FLT3 mutations.
authors.affiliation: Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: D
authors.initials: D
authors.lastname: Monteferrario
authors.affiliation: Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: S M
authors.initials: SM
authors.lastname: Noordermeer
authors.affiliation: Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Bergevoet
authors.affiliation: 1] Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands [2] Department of Hematology, Radboud UMC, Nijmegen, The Netherlands.
authors.forename: G
authors.initials: G
authors.lastname: Huls
authors.affiliation: Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: J H
authors.initials: JH
authors.lastname: Jansen
authors.affiliation: Department of Laboratory Medicine, Laboratory of Hematology, Radboud UMC, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: B A
authors.initials: BA
authors.lastname: van der Reijden
mesh_terms: D000328:Adult; D000368:Aged; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000096:biosynthesis* / Q000235:genetics; D018572:Disease-Free Survival; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology / Q000235:genetics / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics*; D000090243:Nucleophosmin; D015996:Survival Rate; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*; D000097584:DNA Methyltransferase 3B
chemical_list: D004248:DNA (Cytosine-5-)-Methyltransferases; D009687:Nuclear Proteins; D000090243:Nucleophosmin; D051941:fms-Like Tyrosine Kinase 3; D000097584:DNA Methyltransferase 3B; C000716967:NPM1 protein, human; C497970:FLT3 protein, human
references.citation: Cancer Sci. 2010 Jul;101(7):1722-30
references.pmid: 20398054
references.citation: J Clin Oncol. 2011 Jul 20;29(21):2889-96
references.pmid: 21670448
references.citation: Haematologica. 2011 Sep;96(9):1310-7
references.pmid: 21606167
references.citation: Blood. 2008 Mar 1;111(5):2776-84
references.pmid: 17957027
references.citation: Leukemia. 2014 Jan;28(1):78-87
references.pmid: 24045501
references.citation: Cancer Treat Rev. 2011;37 Suppl 1:S13-8
references.pmid: 21612874
references.citation: Leukemia. 2013 Sep;27(9):1803-12
references.pmid: 23757301
references.citation: Blood. 2009 Mar 26;113(13):3088-91
references.pmid: 19171880
references.citation: PLoS One. 2012;7(12):e51527
references.pmid: 23251566
references.citation: Oncogene. 2002 Aug 12;21(35):5483-95
references.pmid: 12154409
references.citation: N Engl J Med. 2008 May 1;358(18):1909-18
references.pmid: 18450602
references.citation: Leukemia. 2011 Aug;25(8):1297-304
references.pmid: 21537333
references.citation: Leukemia. 2013 Jul;27(7):1573-8
references.pmid: 23519389